Clinical
How structured genomic data is reshaping rare disease diagnosis in India
Fragmented records and inconsistent capture slow rare disease diagnosis. Structured genomic workflows are helping referral centers move from suspicion to actionable reports faster.
Rare disease diagnosis in India often depends on information scattered across departments, paper records, and incompatible lab systems. Clinicians spend valuable time reconstructing patient histories instead of interpreting findings.
Structured genomic data capture changes that equation. When phenotypes, family history, prior investigations, and sequencing outputs live in a single longitudinal record, multidisciplinary teams can review cases with far less friction.
At referral hospitals adopting integrated workflows, case preparation time has dropped materially. Geneticists arrive at variant review with complete context, and clinicians can trace how each data point informed the final interpretation.
The shift is not only operational. Better structure improves auditability, supports teaching cases, and creates datasets that institutions can use for quality improvement without compromising patient privacy.
For India's rare disease ecosystem, the lesson is clear: faster diagnosis depends as much on information architecture as on sequencing depth. Platforms that standardize capture and connect clinical and genomic views will define the next phase of scale.
Testing CMS